SCHEMBL6073665

SCHEMBL6073665

O=CC(c1ccc([N+](=O)[O-])cc1)N1CCOCC1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.52
ALDH1A1 P00352 5/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
LMNA P02545 2/20 0.48
KCNJ1 P48048 1/20 0.48
HTT P42858 1/20 0.47
CYP1B1 Q16678 1/20 0.47
AKR1C3 P42330 1/20 0.45
PHGDH O43175 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
KDM4E B2RXH2 2/20 0.43
MEN1 O00255 1/20 0.43
MAPK1 P28482 1/20 0.43
AVPR1A P37288 1/20 0.43
KMT2A Q03164 1/20 0.43
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5239630 0.83 KDM4E (0.49) MAPTALDH1A1SMN1; SMN2LMNAPHGDH
SCHEMBL3935054 0.82 SIRT6 (0.53) MAPTALDH1A1LMNAKCNJ1CYP1A2
SCHEMBL27472363 0.82 ADRB1 (0.53) MAPTALDH1A1KCNJ1CYP1A2KDM4E
SCHEMBL5302719 0.82 MAPT (0.43) MAPTALDH1A1SMN1; SMN2LMNACYP1A2
Hydrochloric Acid SCHEMBL27455896 0.81 ADRB1 (0.51) MAPTALDH1A1KCNJ1CYP1A2KDM4E
SCHEMBL2085614 0.79 MAPT (0.62) MAPTALDH1A1SMN1; SMN2LMNAKCNJ1
SCHEMBL6631373 0.78 NPC1 (0.37) MAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL4073260 0.78 MGLL (0.41) MAPTALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL1516145 0.78 ALDH1A1 (0.50) ALDH1A1LMNA
SCHEMBL12068487 0.78 ALDH1A1 (0.50) ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006118749-A1 THIA-TETRAAZAACENAPHTHYLENE KINASE INHIBITORS JANSSEN PHARMACEUTICA, N.V. (BE) 2006-11-09 WO disclosed
EP-1436291-A2 INDOLIZINES AS KINASE PROTEIN INHIBITORS Aventis Pharma S.A. (FR) 2004-07-14 EP disclosed
WO-2003024967-A2 INDOLIZINES AS KINASE PROTEIN INHIBITORS AVENTIS PHARMA S.A. (FR) 2003-03-27 WO disclosed